Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review

被引:187
作者
Gill, Richdeep S. [2 ]
Birch, Daniel W. [1 ]
Shi, Xinzhe [1 ]
Sharma, Arya M. [3 ]
Karmali, Shahzeer [1 ]
机构
[1] Royal Alexandria Hosp, Ctr Advancement Minimally Invas Surg, Edmonton, AB T5H 3V9, Canada
[2] Univ Alberta, Dept Surg, Edmonton, AB, Canada
[3] Univ Alberta, Dept Med, Edmonton, AB, Canada
关键词
Sleeve gastrectomy; Type 2 diabetes mellitus; Obesity; Bariatric surgery; Y GASTRIC BYPASS; INTENTIONAL WEIGHT-LOSS; BILIOPANCREATIC DIVERSION; METABOLIC SYNDROME; SURGICAL-TREATMENT; OBESE-PATIENTS; SURGERY; OVERWEIGHT; REDUCTION; APPETITE;
D O I
10.1016/j.soard.2010.07.011
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Background: Existing evidence has suggested that bariatric surgery produces sustainable weight loss and remission or cure of type 2 diabetes mellitus (DM). Laparoscopic sleeve gastrectomy (LSG) has garnered considerable interest as a low morbidity bariatric surgical procedure that leads to effective weight loss and control of co-morbid disease. The objective of the present study was to systematically review the effect of LSG on type 2 DM. Methods: An electronic data search of MEDLINE, PubMed, Embase, Scopus, Dare, Clinical Evidence, TRIP, Health Technology Database, Conference abstracts, clinical trials, and the Cochrane Library database was completed. The search terms used included LSG, vertical gastrectomy, bariatric surgery, metabolic surgery, and diabetes (DM), type 2 DM, or co-morbidities. All human studies, not limited to those in the English language, that had been reported from 2000 to April 2010 were included. Results: After an initial screen of 3621 titles, 289 abstracts were reviewed, and 28 studies met the inclusion criteria and the full report was assessed. One study was excluded after a careful assessment because the investigators had combined LSG with ileal interposition. A total of 27 studies and 673 patients were analyzed. The baseline mean body mass index for the 673 patients was 47.4 kg/m(2) (range 31.0-53.5). The mean percentage of excess weight loss was 47.3% (range 6.3-74.6%), with a mean follow-up of 13.1 months (range 3-36). DM had resolved in 66.2% of the patients, improved in 26.9%, and remained stable in 13.1%. The mean decrease in blood glucose and hemoglobin Alc after sleeve gastrectomy was -88.2 mg/dL and -1.7%, respectively. Conclusion: Most patients with type 2 DM experienced resolution or improvement in DM markers after LSG. LSG might play an important role as a metabolic therapy for patients with type 2 DM. (Surg Obes Relat Dis 2010;6:707-713.) (C) 2010 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:707 / 713
页数:7
相关论文
共 49 条
[1]
Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes [J].
Abbatini, F. ;
Rizzello, M. ;
Casella, G. ;
Alessandri, G. ;
Capoccia, D. ;
Leonetti, F. ;
Basso, N. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2010, 24 (05) :1005-1010
[2]
BASSO N, OB SURG IFSO 2009
[3]
BERRY M, OB SURG IFSO 2009
[4]
Bariatric surgery: A systematic review and meta-analysis [J].
Buchwald, H ;
Avidor, Y ;
Braunwald, E ;
Jensen, MD ;
Pories, W ;
Fahrbach, K ;
Schoelles, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (14) :1724-1737
[5]
CHOWBEY PK, OBES SURG
[6]
Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity [J].
Cottam, D. ;
Qureshi, F. G. ;
Mattar, S. G. ;
Sharma, S. ;
Holover, S. ;
Bonanomi, G. ;
Ramanathan, R. ;
Schauer, P. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2006, 20 (06) :859-863
[7]
[8]
Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus [J].
DePaula, A. L. ;
Macedo, A. L. V. ;
Rassi, N. ;
Vencio, S. ;
Machado, C. A. ;
Mota, B. R. ;
Silva, L. Q. ;
Halpern, A. ;
Schraibman, V. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2008, 22 (12) :2670-2678
[9]
Glucagon-like peptide-1 and the islet β-cell:: Augmentation of cell proliferation and inhibition of apoptosis [J].
Drucker, DJ .
ENDOCRINOLOGY, 2003, 144 (12) :5145-5148
[10]
Is There Any Role of Resecting the Stomach to Ameliorate Weight Loss and Sugar Control in Morbidly Obese Diabetic Patients? [J].
Frezza, Eldo E. ;
Wozniak, Susan E. ;
Gee, Laura ;
Wacthel, Mitchell .
OBESITY SURGERY, 2009, 19 (08) :1139-1142